Blood Collection Tubes under EU IVDR

Regulatory Challenges for Blood Collection Tubes under EU IVDR in Germany

Introduction: EU IVDR and Its Impact on Blood Collection Tubes

The regulatory environment for blood collection tubes under EU IVDR in Europe has undergone a fundamental transformation with the enforcement of the European Union In Vitro Diagnostic Regulation (EU IVDR 2017/746). Devices that were previously regulated as low-risk products under the In Vitro Diagnostic Directive (IVDD) are now subject to significantly higher regulatory scrutiny.

Blood collection tubes under EU IVDR, which are essential to pre-analytical laboratory processes, must now comply with enhanced regulatory requirements, including more rigorous documentation, performance evaluation, and conformity assessment procedures. 

Let's Grow Your Business Together

For manufacturers and distributors targeting Germany—one of the most strictly regulated healthcare markets in the EU—understanding the implications of blood collection tubes under the IVDR is critical to maintaining CE marking and ensuring uninterrupted market access.

Regulatory Classification of Blood Collection Tubes under EU IVDR

Under EU IVDR, Blood Collection Tubes are classified as in vitro diagnostic medical devices, as they are intended for the collection, preservation, and transport of human specimens for diagnostic examination.

IVDR Classification and Its Regulatory Implications

According to IVDR classification rules:

  • Class A (Non-Sterile Blood Collection Tubes)
    → Self-declared by the manufacturer
  • Class A (Sterile Blood Collection Tubes)
    → Mandatory involvement of an IVDR-designated Notified Body

 

Key Regulatory Challenge

Incorrect classification of Blood Collection Tubes can result in:

  • Non-compliance with IVDR requirements
  • Delays in CE marking
  • Market access restrictions in Germany

Accurate classification is therefore a foundational regulatory requirement.

CE Marking Requirements for Blood Collection Tubes under EU IVDR

Achieving CE marking for Blood Collection Tubes is one of the most critical regulatory milestones under IVDR.

Core Compliance Requirements

Manufacturers must demonstrate conformity with:

  • General Safety and Performance Requirements (GSPR – Annex I)
  • ISO 13485 – Quality Management System
  • ISO 14971 – Risk Management
  • Performance Evaluation, including:
    • Impact of additives (EDTA, citrate, heparin)
    • Interaction with downstream diagnostic assays
  • Sterility Validation (for sterile Blood Collection Tubes)

Germany-Specific CE Marking Challenges for Blood Collection Tubes

Germany presents unique regulatory challenges under EU IVDR, particularly for low-risk IVDs such as blood collection tubes.

Key Market Barriers in Germany

  • Limited number of IVDR-designated Notified Bodies, including:
    • TÜV SÜD
    • TÜV Rheinland
    • DEKRA
  • Extended review timelines due to high submission volumes
  • Increased documentation expectations, even for Class A devices

These factors frequently lead to delays in CE certification and can impact product availability in the German market.

How Operon Strategist Supports EU IVDR Compliance for Blood Collection Tubes?

Operon Strategist provides end-to-end regulatory support for manufacturers of Blood Collection Tubes, enabling efficient and compliant market access under EU IVDR and beyond.

Our Expertise Includes:

  • CE marking strategy for Blood Collection Tubes under EU IVDR
  • IVDR classification and conformity assessment support
  • Technical documentation preparation (Annex II & III)
  • GSPR gap analysis and remediation
  • Notified Body coordination and submission management
  • US FDA
  • MHRA (UK)
  • SFDA
  • Egyptian Drug Authority (EDA)
  • CDSCO (India)

With a foundation built on global regulatory expertise, technical precision, and regulatory trust, Operon Strategist helps manufacturers of blood collection tubes reduce compliance risks, avoid market disruptions, and accelerate approvals across global markets.

Get Expert IVDR Guidance and Secure CE Marking for Your Blood Collection Tubes

FAQ

Yes, blood collection tubes are generally classified as In Vitro Diagnostic (IVD) medical devices under the EU IVDR. They are specifically intended by the manufacturer to be used for the collection and preparation of specimens derived from the human body for the purpose of in vitro examination.

Blood collection tubes are generally classified as Class A under the EU IVDR.
As they are non-measuring, non-sterile, and do not fall into higher-risk categories, they qualify for the lowest risk classification.

Yes, CE marking is mandatory for all blood collection tubes marketed in the EU under the IVDR. Manufacturers must complete the required conformity assessment process to affix the mark before placing these devices on the market.

Manufacturers must ensure compliance with the General Safety and Performance Requirements (GSPR) in Annex I, covering technical documentation, chemical safety, and labeling. They must also maintain a Quality Management System (QMS), typically aligned with ISO 13485, and perform continuous post-market surveillance activities.